These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6860615)

  • 1. Sustained release of carmustine (BCNU) for treatment of experimental intraocular malignancy.
    Liu LH; Refojo MF; Ni C; Ueno N; Albert DM
    Br J Ophthalmol; 1983 Jul; 67(7):479-84. PubMed ID: 6860615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of BCNU for the treatment of intraocular malignancies in animal models.
    Liu HS; Refojo MF; Perry HD; Albert DM
    Invest Ophthalmol Vis Sci; 1979 Oct; 18(10):1061-7. PubMed ID: 478776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental combined systemic and local chemotherapy for intraocular malignancy.
    Liu HS; Refojo MF; Albert DM
    Arch Ophthalmol; 1980 May; 98(5):905-8. PubMed ID: 7378013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct delivery of anticancer agents: experimental treatment of intraocular malignancy.
    Liu HS; Refojo MF; Perry HD; Albert DM
    Invest Ophthalmol Vis Sci; 1978 Oct; 17(10):993-1004. PubMed ID: 700954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic changes following carmustine treatment of uveal Greene melanoma in rabbits.
    Ni C; Liu LH
    Graefes Arch Clin Exp Ophthalmol; 1983; 220(3):103-9. PubMed ID: 6852549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary malignant melanoma metastatic to vitreous humor of the eye: treatment with BCNU.
    Murray JL
    South Med J; 1983 Apr; 76(4):523-6. PubMed ID: 6836373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical administration of the antineoplastic carmustine: tolerance of normal rabbit eyes.
    Henriquez AS; Liu LH; Refojo MF
    Curr Eye Res; 1981; 1(3):183-7. PubMed ID: 7297103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hamster Greene melanoma implanted in the anterior chamber of a rabbit eye: a reliable tumor model?
    Römer TJ; van Delft JL; de Wolff-Rouendaal D; Jager MJ
    Ophthalmic Res; 1992; 24(2):119-24. PubMed ID: 1608597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance of normal rabbit eyes to the antineoplastic carmustine.
    Liu HS; Perry HD; Refojo MF
    Ophthalmologica; 1980; 181(1):41-6. PubMed ID: 7207972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
    Emerich DF; Winn SR; Bartus RT
    Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of a nitrosourea derivative from refillable silicone rubber implants for the treatment of intraocular malignancies.
    Refojo MF; Liu HS; Leong FL; Sidebottom D
    J Bioeng; 1978; 2(5):437-45. PubMed ID: 744769
    [No Abstract]   [Full Text] [Related]  

  • 12. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
    Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
    Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release rate of a lipophilic drug (BCNU) from a refillable silicone rubber device.
    Ueno N; Refojo MF; Liu LH
    J Biomed Mater Res; 1982 Sep; 16(5):669-77. PubMed ID: 7130219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.
    Yang MB; Tamargo RJ; Brem H
    Cancer Res; 1989 Sep; 49(18):5103-7. PubMed ID: 2766281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures.
    Grasso RJ; Johnson CE; Boler RK; Moore NA
    Cancer Res; 1977 Feb; 37(2):585-94. PubMed ID: 832280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriochlorin a, a new photosensitizer in photodynamic therapy. In vivo results.
    Schuitmaker JJ; van Best JA; van Delft JL; Dubbelman TM; Oosterhuis JA; de Wolff-Rouendaal D
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1444-50. PubMed ID: 2387678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers.
    Grossman SA; Reinhard C; Colvin OM; Chasin M; Brundrett R; Tamargo RJ; Brem H
    J Neurosurg; 1992 Apr; 76(4):640-7. PubMed ID: 1545259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.